ID: ALA3705314
Type: Binding
Description: Glucagon SPA Assay: The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.
Organism: Homo sapiens
Bioactivity
Activity Types for Assay ALA3705314
Ki
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
476.46 | 3.84 | 3.84 |
457.53 | 5.15 | 5.15 |
476.46 | 4.41 | 4.41 |
477.44 | 3.81 | 3.81 |
425.46 | 4.14 | 4.14 |
489.49 | 5.32 | 5.32 |
516.52 | 4.48 | 4.48 |
455.94 | 4.96 | 4.96 |
463.58 | 5.34 | 5.34 |
489.49 | 5.23 | 5.23 |
501.51 | 4.83 | 4.83 |
515.54 | 5.22 | 5.22 |
503.53 | 5.00 | 5.00 |
487.48 | 4.44 | 4.44 |
487.48 | 4.44 | 4.44 |
493.46 | 4.58 | 4.58 |
489.50 | 4.75 | 4.75 |
515.54 | 5.08 | 5.08 |
471.56 | 5.46 | 5.46 |
529.56 | 5.53 | 5.53 |
483.57 | 5.54 | 5.54 |
467.96 | 4.47 | 4.47 |
501.39 | 4.21 | 4.21 |
489.62 | 5.11 | 5.11 |
475.59 | 4.94 | 4.94 |
471.56 | 5.46 | 5.46 |
471.56 | 5.46 | 5.46 |
471.56 | 5.46 | 5.46 |
471.56 | 5.46 | 5.46 |
483.57 | 5.09 | 5.09 |
469.97 | 5.27 | 5.27 |
529.56 | 6.02 | 6.02 |
484.56 | 4.49 | 4.49 |
484.56 | 5.06 | 5.06 |
515.53 | 5.63 | 5.63 |
491.98 | 5.80 | 5.80 |
491.98 | 5.80 | 5.80 |
503.52 | 5.63 | 5.63 |
475.59 | 5.49 | 5.49 |
504.51 | 5.03 | 5.03 |
490.48 | 4.72 | 4.72 |
543.59 | 6.27 | 6.27 |
519.52 | 5.33 | 5.33 |
523.46 | 4.69 | 4.69 |
489.49 | 5.32 | 5.32 |
483.57 | 5.09 | 5.09 |
481.98 | 4.78 | 4.78 |
484.56 | 4.49 | 4.49 |
497.60 | 5.43 | 5.43 |
517.55 | 5.31 | 5.31 |
517.55 | 5.31 | 5.31 |
529.56 | 5.45 | 5.45 |
447.54 | 4.30 | 4.30 |
517.51 | 4.07 | 4.07 |
489.50 | 4.69 | 4.69 |
511.45 | 5.29 | 5.29 |
475.52 | 5.29 | 5.29 |
475.52 | 5.29 | 5.29 |
485.58 | 5.77 | 5.77 |
515.54 | 5.08 | 5.08 |
476.46 | 3.84 | 3.84 |
502.50 | 4.23 | 4.23 |
485.58 | 5.77 | 5.77 |
515.54 | 5.08 | 5.08 |
515.54 | 5.08 | 5.08 |
463.58 | 4.72 | 4.72 |
463.58 | 4.72 | 4.72 |
490.49 | 4.08 | 4.08 |
490.49 | 4.08 | 4.08 |
515.54 | 5.22 | 5.22 |
515.54 | 5.22 | 5.22 |
517.51 | 4.44 | 4.44 |
545.56 | 4.92 | 4.92 |
544.58 | 4.95 | 4.95 |